David J. Mulholland

5.8k total citations
50 papers, 4.4k citations indexed

About

David J. Mulholland is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David J. Mulholland has authored 50 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in David J. Mulholland's work include Prostate Cancer Treatment and Research (20 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and Cancer-related gene regulation (6 papers). David J. Mulholland is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and Cancer-related gene regulation (6 papers). David J. Mulholland collaborates with scholars based in United States, Canada and China. David J. Mulholland's co-authors include Hong Wu, Shoukat Dedhar, Colleen C. Nelson, A. Wayne Vogl, Marcus Ruscetti, Linh M. Tran, Jiaoti Huang, Gerhard A. Coetzee, Martin Gleave and Paul S. Rennie and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David J. Mulholland

50 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Mulholland United States 28 2.9k 1.2k 1.2k 937 451 50 4.4k
Gustavo Baldassarre Italy 40 3.4k 1.2× 449 0.4× 1.6k 1.4× 1.8k 1.9× 374 0.8× 134 5.1k
Giovanna Chiorino Italy 37 3.0k 1.0× 532 0.4× 1.3k 1.1× 1.3k 1.3× 249 0.6× 113 4.8k
Stefano Pepe Italy 45 2.6k 0.9× 1.1k 0.9× 2.5k 2.1× 647 0.7× 366 0.8× 130 5.3k
Bassem R. Haddad United States 33 2.4k 0.8× 466 0.4× 1.0k 0.9× 718 0.8× 1.0k 2.2× 81 4.4k
Fiona Kaper United States 18 2.6k 0.9× 736 0.6× 780 0.7× 2.2k 2.3× 349 0.8× 24 4.1k
Naomi Goldfinger Israel 50 4.3k 1.5× 429 0.3× 3.2k 2.7× 1.5k 1.6× 478 1.1× 93 6.2k
Guro E. Lind Norway 39 3.0k 1.1× 764 0.6× 1.3k 1.2× 1.5k 1.6× 317 0.7× 89 4.8k
Yoshitaka Hippo Japan 27 2.1k 0.7× 278 0.2× 892 0.8× 681 0.7× 215 0.5× 64 3.3k
Sophie Vacher France 39 2.6k 0.9× 587 0.5× 1.5k 1.3× 1.5k 1.6× 448 1.0× 142 4.5k
Sarki A. Abdulkadir United States 38 2.6k 0.9× 998 0.8× 1.2k 1.1× 881 0.9× 302 0.7× 93 4.4k

Countries citing papers authored by David J. Mulholland

Since Specialization
Citations

This map shows the geographic impact of David J. Mulholland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Mulholland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Mulholland more than expected).

Fields of papers citing papers by David J. Mulholland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Mulholland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Mulholland. The network helps show where David J. Mulholland may publish in the future.

Co-authorship network of co-authors of David J. Mulholland

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Mulholland. A scholar is included among the top collaborators of David J. Mulholland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Mulholland. David J. Mulholland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lin, Yitian Xu, Kyeongah Kang, et al.. (2022). World Trade Center Dust Exposure Promotes Cancer in PTEN-deficient Mouse Prostates. Cancer Research Communications. 2(6). 518–532. 1 indexed citations
2.
Sfakianos, John P., Yang Hu, Jorge Daza, et al.. (2022). Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT–Stromal and Tgfβ-Dependent Mechanisms. Molecular Cancer Therapeutics. 21(11). 1729–1741. 2 indexed citations
3.
Ranea‐Robles, Pablo, Aaron Bender, Kyung Lee, et al.. (2021). Peroxisomal L-bifunctional Protein Deficiency Causes Male-specific Kidney Hypertrophy and Proximal Tubular Injury in Mice. Kidney360. 2(9). 1441–1454. 16 indexed citations
4.
Sfakianos, John P., Jorge Daza, Yang Hu, et al.. (2020). Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers. Nature Communications. 11(1). 2540–2540. 40 indexed citations
5.
Öztürk, Sait, Deepti Mathur, Royce Zhou, David J. Mulholland, & Ramon Parsons. (2020). Leflunomide triggers synthetic lethality in PTEN-deficient prostate cancer. Prostate Cancer and Prostatic Diseases. 23(4). 718–723. 7 indexed citations
6.
Lieberman‐Cribbin, Wil, Stephanie Tuminello, Christina Gillezeau, et al.. (2019). Complementary biobank of rodent tissue samples to study the effect of World Trade Center exposure on cancer development. Journal of Translational Medicine. 17(1). 342–342. 5 indexed citations
7.
Wang, Li, Abdel Saci, Péter M. Szabó, et al.. (2018). EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nature Communications. 9(1). 3503–3503. 216 indexed citations
8.
Roubaud, Guilhem, et al.. (2016). Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer. Nature Reviews Clinical Oncology. 14(5). 269–283. 37 indexed citations
9.
Ruscetti, Marcus, et al.. (2015). Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Research. 75(13). 2749–2759. 173 indexed citations
10.
Mulholland, David J.. (2014). Abstract LB-44: Persistent androgen ablation promotes enhanced neuroendocrine features in Pten-deficient prostate cancer. Cancer Research. 74(19_Supplement). LB–44. 1 indexed citations
11.
Mulholland, David J., Naoko Kobayashi, Marcus Ruscetti, et al.. (2012). Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells. Cancer Research. 72(7). 1878–1889. 385 indexed citations
12.
Vizio, Dolores Di, Matteo Morello, Andrew C. Dudley, et al.. (2012). Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease. American Journal Of Pathology. 181(5). 1573–1584. 331 indexed citations
13.
Santiskulvong, Chintda, Gottfried E. Konecny, Kuang-Yui Michael Chen, et al.. (2011). Dual Targeting of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach in Human Ovarian Carcinoma. Clinical Cancer Research. 17(8). 2373–2384. 100 indexed citations
14.
Mulholland, David J., et al.. (2009). Lin−Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten -Null Prostate Cancer Model. Cancer Research. 69(22). 8555–8562. 143 indexed citations
15.
Mosessian, Sherly, Nuraly K. Avliyakulov, David J. Mulholland, et al.. (2009). Analysis of PTEN Complex Assembly and Identification of Heterogeneous Nuclear Ribonucleoprotein C as a Component of the PTEN-associated Complex. Journal of Biological Chemistry. 284(44). 30159–30166. 18 indexed citations
16.
Santiskulvong, Chintda, et al.. (2008). Dual inhibition of phosphoinositide 3-kinase and mammalian target of rapamycin as a novel therapeutic approach in human ovarian carcinoma. Cancer Research. 68. 4970–4970. 1 indexed citations
17.
Mulholland, David J., Jing Jiao, & Hong Wu. (2008). Hormone Refractory Prostate Cancer: Lessons Learned from the PTEN Prostate Cancer Model. Advances in experimental medicine and biology. 617. 87–95. 7 indexed citations
18.
Kojima, Satoko, David J. Mulholland, Susan Ettinger, et al.. (2006). Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models. The Prostate. 66(9). 971–986. 27 indexed citations
19.
Kojima, Satoko, et al.. (2005). Differentially androgen regulated genes in androgen dependent (LNCaP) and independent (C4-2) prostate cancer cells. Cancer Research. 65. 1034–1034. 2 indexed citations
20.
Tubb, Benjamin, David J. Mulholland, A. Wayne Vogl, et al.. (2002). Testis Fascin (FSCN3): A Novel Paralog of the Actin-Bundling Protein Fascin Expressed Specifically in the Elongate Spermatid Head. Experimental Cell Research. 275(1). 92–109. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gustavo Baldassarre Breakdown of academic impact, for papers by Giovanna Chiorino Breakdown of academic impact, for papers by Stefano Pepe Breakdown of academic impact, for papers by Bassem R. Haddad Breakdown of academic impact, for papers by Fiona Kaper Breakdown of academic impact, for papers by Naomi Goldfinger Breakdown of academic impact, for papers by Guro E. Lind Breakdown of academic impact, for papers by Yoshitaka Hippo Breakdown of academic impact, for papers by Sophie Vacher Breakdown of academic impact, for papers by Sarki A. Abdulkadir
Rankless by CCL
2026